The effects of zotepine in treating psychotic patients with hyperuricaemia: A case series [2]

International Journal of Neuropsychopharmacology

Volumn 9, Issue 2, 2006, Pages 259-261

  Chen, Tzu Ting ^a   Chen, Jen Yeu ^a   Bai, Ya Mei ^a,b   Lin, Chao Cheng ^a,c  

^a YULI VETERANS HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CHLORPROMAZINE; COLCHICINE; FLUPENTIXOL DECANOATE; HALOPERIDOL; NEUROLEPTIC AGENT; SULPIRIDE; THIORIDAZINE; URIC ACID; ZOTEPINE;

ADULT; AGED; ANAMNESIS; CASE REPORT; COMORBIDITY; DRUG EFFECT; DRUG SUBSTITUTION; FEMALE; GOUT; HUMAN; HYPERURICEMIA; LETTER; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; PSYCHOSIS; REMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOM; URIC ACID BLOOD LEVEL;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; DIBENZOTHIEPINS; FEMALE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS;

EID: 32844466632     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145705005675     Document Type: Letter

References (7)

1. Bloch M, Gur E, Shalev AY (1992). Hypouricemic effect of zuclopenthixol: a potential marker of drug compliance? Psychopharmacology 109, 377-378.
2. Lin CC, Bai YM, Chen JY, Wang YC, Liou YJ, Chao CH, Lai IC, Tsai KY, Chiu HJ (2003). Switching from clozapine to zotepine in schizophrenic patients: a randomized, single-blind controlled study. European Neuropsychopharmacology 13 (Suppl. 4), S318.
3. Petit M, Raniwalla J, Tweed J, Leutenegger E, Dollfus S, Kelly F (1996). A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial. Psychopharmacology Bulletin 32, 81-87.
4. Reddy R, Keshavan M, Yao JK (2003). Reduced plasma antioxidants in first-episode patients with schizophrenia. Schizophrenia Research 62, 205-212. doi:10.1016/S0920-9964(02)00407-3.
5. Shalev A, Hermesh H, Munitz H (1987). The hypouricemic effect of chlorprothixene. Clinical Pharmacology and Therapeutics 42, 562-566.
6. Yao JK, Reddy R, Kammen DP (1998). Reduced level of plasma antioxidant uric acid in schizophrenia. Psychiatry Research 80, 29-39.
7. Yoshida H, Kaiya H, Kondo T, Sanpei F, Takeda N, Takeuchi K (1982). Effects of zotepine, a psychotropic agent, on the serum uric acid level of inpatients at a psychiatric hospital. Japanese Journal of Psychopharmacology 2, 69-76.